Cardio Diagnostics Holdings, INC Form 4 insider transactions

Peter K. Fung, a Director at Cardio Diagnostics Holdings, Inc., acquired stock options on June 30, 2026, as detailed in a Form 4 filing.

Cardio Diagnostics Holdings, Inc. Director Wendy J. Betts reported a transaction involving the acquisition of stock options and subsequent exercise, impacting her beneficial ownership.

Cardio Diagnostics Holdings, Inc. Director James Intrater acquired stock options, indicating a potential future investment in the company.

Paul Frederick Burton, a Director at Cardio Diagnostics Holdings, Inc., reported the acquisition of stock options and subsequent exercise, increasing his beneficial ownership.

Director Peter K. Fung acquired 3,205 stock options in Cardio Diagnostics Holdings, Inc. as part of a routine equity grant.

Director Wendy J. Betts was granted 3,205 stock options in Cardio Diagnostics Holdings, Inc. as part of a routine equity compensation.

Cardio Diagnostics Holdings, Inc. director James Intrater was granted 3,205 stock options as part of a compensation event.

Director Paul Frederick Burton was granted 3,205 stock options in Cardio Diagnostics Holdings, Inc. on March 31, 2026.

Cardio Diagnostics Holdings Director Peter K Fung acquired 2,306 stock options with an exercise price of $2.71, effective December 31, 2025.

Cardio Diagnostics Holdings Director Wendy J Betts acquired 2,306 stock options at an exercise price of $2.71 per share under a pre-arranged plan.

Cardio Diagnostics Holdings Director James Intrater acquired 2,306 stock options at an exercise price of $2.71, increasing his beneficial ownership to 7,259 derivative securities.

Cardio Diagnostics Holdings Director Paul Frederick Burton reported the acquisition of 2,306 stock options with an exercise price of $2.71, exercisable from December 31, 2025, and expiring in 2035.

Cardio Diagnostics Holdings Director Peter K Fung acquired 1,559 stock options with an exercise price of $4.01.

Cardio Diagnostics Holdings Director Wendy J Betts acquired 1,559 stock options with an exercise price of $4.01, increasing her beneficial ownership to 4,002 derivative securities.

Cardio Diagnostics Holdings Director James Intrater reported the acquisition of 1,559 stock options with an exercise price of $4.01, exercisable from September 30, 2025.

Cardio Diagnostics Holdings Director Paul Burton acquired 1,559 stock options with an exercise price of $4.01, increasing his beneficial ownership to 4,953 derivative securities.

Cardio Diagnostics Holdings, Inc. Director Peter K Fung reported a planned acquisition of 1,736 stock options at an exercise price of $3.6 per share, effective June 30, 2025, under a Rule 10b5-1 plan.

Cardio Diagnostics Holdings, Inc. Director Wendy J Betts acquired 1,736 stock options with an exercise price of $3.60, effective June 30, 2025.

Cardio Diagnostics Holdings, Inc. Director James Intrater acquired 1,736 stock options at an exercise price of $3.60, increasing his total beneficial ownership of derivative securities to 3,394.

Cardio Diagnostics Holdings, Inc. Director Paul Burton reported the acquisition of 1,736 stock options with an exercise price of $3.6, effective June 30, 2025.

Director Peter K Fung of Cardio Diagnostics Holdings, Inc. reports acquiring stock options and disposing of derivative securities.

Director Wendy J. Betts of Cardio Diagnostics Holdings, Inc. reports acquiring stock options and disposing of derivative securities.

Director Paul Frederick Burton of Cardio Diagnostics Holdings, Inc. reports acquiring stock options and disposing of derivative securities on March 31, 2025.

James Intrater, a director of Cardio Diagnostics Holdings, acquired 18,939 stock options at an exercise price of $0.33 on March 31, 2025.

Director Paul Frederick Burton reports acquisition and disposal of stock options in Cardio Diagnostics Holdings, Inc.

Director James Intrater acquired 4,544 stock options in Cardio Diagnostics Holdings on December 31, 2024, while disposing of 30,805 stock options.

Director Oded Levy reports acquisition of stock options and disposal of derivative securities at Cardio Diagnostics Holdings.

Director Stanley K. Lau of Cardio Diagnostics Holdings, Inc. reports acquiring stock options and disposing of derivative securities.

Director James Intrater reports acquisition and disposal of stock options in Cardio Diagnostics Holdings.

Paul Frederick Burton, a director of Cardio Diagnostics Holdings, Inc., reports acquiring and disposing of stock options on September 30, 2024.